108
Views
4
CrossRef citations to date
0
Altmetric
Conference Proceedings

Toll-Like receptor 4 (TLR4) polymorphism rs2149356 and risk of gout in a Spanish cohort

ORCID Icon
Pages 1424-1431 | Received 11 Sep 2019, Accepted 04 Jun 2020, Published online: 18 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jordana Dinorá de Lima, André Guilherme Portela de Paula, Bruna Sadae Yuasa, Caio Cesar de Souza Smanioto, Maria Clara da Cruz Silva, Priscila Ianzen dos Santos, Karin Braun Prado, Angelica Beate Winter Boldt & Tárcio Teodoro Braga. (2023) Genetic and Epigenetic Regulation of the Innate Immune Response to Gout. Immunological Investigations 52:3, pages 364-397.
Read now

Articles from other publishers (3)

Jinli Luo, Shuo Chen, Naiwen Zhang, Shengnan Gao & Chunli Piao. (2023) Investigation of the mechanism of action of simiao pill against gout using network pharmacology and experimental validation. Journal of Herbal Medicine 41, pages 100693.
Crossref
Songsong Jiang, Qian Li, Shiwen Han, Hengpeng Wang, Xinlei Tang, Tao Wang & Xiangren Meng. (2023) Study on the anti‐inflammatory effect of stachyose by inhibiting TLR4 / NF‐κB signalling pathway in vitro and in vivo . Clinical and Experimental Pharmacology and Physiology 50:7, pages 573-582.
Crossref
Denise Clavijo‐Cornejo, Olivia Hernández‐González & Marwin Gutierrez. (2021) The current role of NLRP3 inflammasome polymorphism in gout susceptibility. International Journal of Rheumatic Diseases 24:10, pages 1257-1265.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.